Smoking is associated with a decrease in body weight in patients without diabetes mellitus and an increase in insulin resistance and hemoglobin A1c (HbA1c) levels in patients with type 1 diabetes mellitus. Whether smoking is associated with an increase in HbAlc and/or a decrease in body mass index (BMI) in type 2 diabetes mellitus is unresolved, however. Therefore, the objective of this study was to determine the effect of smoking on HbAlc levels and BMI in a cross-section of outpatients with type 2 diabetes mellitus.
Methods
A questionnaire was completed by 102 sequential outpatients (32 men, 70 women) with type 2 diabetes mellitus to assess age, sex, duration of diabetes mellitus, medications, exposure to nicotine, medical complications as a result of type 2 diabetes mellitus, and BMI. In addition, a urine sample was obtained from each patient to assess the microalbumin-creatinine and cotinine-creatinine ratios. HbAlc level were also obtained from each volunteer as a measure of glucose control.
Results
Smokers had significantly higher cotinine-creat-inine ratios than nonsmokers. Smokers and nonsmokers did not differ significantly with regard to HbAlc level, BMI, or duration of diabetes mellitus. Smokers were younger than nonsmokers. Smokers and nonsmokers did not differ significantly in terms of microalbumin-creatinine ratio, amount of diabetic medications, or medical complications.
Conclusion
The results of this study suggest that smoking does not have a significant direct effect on BMI or HbAlc in patients with type 2 diabetes mellitus. This conclusion suggests that the relationship between these factors is much more complex than in people without diabetes or in patients with type 1 diabetes mellitus.
LundmanBMAsplundKNorbergA.Smoking and metabolic control in patients with insulin-dependent diabetes mellitus.J Intern Med1990; 227: 101–106.
2.
AttvallSFowelinJLagerIVon SchenckH, Smith U. Smoking induces insulin resistance: A potential link with the insulin resistance syndrome.J Intern Med1993; 233: 327–332.
3.
TargherGAlbericheMZenereMBBonadonnaRCMuggeoMBonoraE.Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus.J Clin Endocrinol Metab1997; 82: 3619–3624.
4.
SimonDSenanCGarnierPSaint-PaulMPapozL.Epidemiological features of glycated haemoglobin Alc-distribution in a healthy population: The Telecom Study.Diabetologia1989; 32: 864–869.
5.
BenowitzNL.Cotinine as a biomarker of environmental tobacco smoke exposure.Epidemiol Rev1996; 18: 188–204.
6.
EkstrandAVGroopPHGronhagen-RiskaC.Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus.Nephrol Dial Transplant1998; 13: 3079–3083.
7.
PoulsenPLMogensenCE.Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-to-creatinine ratio: A brief report.Diabetes Care1998; 21: 97–98.
FacchiniFSHollenbeckCBJeppesenJChenYDReavenGM.Insulin resistance and cigarette smoking.Lancet1992; 339: 1128–1130.
10.
KannelWB.Update on the role of cigarette smoking in coronary artery disease.Am Heart J1981; 101: 319–328.
11.
OlofssonBODahlenGNilssonTK.Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.Eur Heart J1989; 10: 77–82.
12.
EckLHHackett-RennerCKlesgesLM.Impact of diabetic status, dietary intake, physical activity, and smoking status on body mass index in NHANES II.Am J Clin Nutr1992; 56: 329–333.
13.
NilssonPMLindLPollareTBerneCLithellHO.Increased level of hemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers.Metabolism1995; 44: 557–561.
